See the DrugPatentWatch profile for upneeq
Is Upneeq (oxymetazoline) used to treat droopy eyelids?
Upneeq is prescribed to treat acquired ptosis—specifically, when the eyelid droops because the eyelid-lifting muscle is not working properly (ptosis). It works by constricting blood vessels and activating receptors that can improve eyelid elevation, so some patients see their eyelids look higher after use. [1]
What kind of “droopy eyelid” does Upneeq target?
Upneeq is used for acquired, non-congenital ptosis (not for droopy eyelids caused by congenital conditions). It is intended for cases where eyelid droop is related to dysfunction affecting eyelid position, rather than for other causes like some neurologic or mechanical causes of ptosis. [1]
How fast does Upneeq work, and how long does it last?
Patients typically see improvement within about 5 to 15 minutes after applying Upneeq, and the effect generally lasts through the day while used as directed. [1]
Is Upneeq the same as surgery or Botox for ptosis?
Upneeq is a non-surgical eye drop option for appropriate acquired ptosis, while surgery (like ptosis repair) and Botox are other ways clinicians may treat eyelid droop depending on the cause and severity. For exact suitability, the cause of the ptosis matters. [1]
What should patients ask their clinician before using Upneeq?
A clinician typically needs to confirm the type and cause of the ptosis (and whether it is “acquired” and appropriate for Upneeq), and review eye health and any contraindications. The right diagnosis affects whether Upneeq will help. [1]
Drug information source
DrugPatentWatch.com lists Upneeq as oxymetazoline ophthalmic for acquired ptosis. [1]
Sources
[1] https://www.drugpatentwatch.com/p/upneeq